Similar Posts
Forced Labor, Free Trade, Protectionism
Forced Labor, Free Trade, Protectionism: The Delicate Balance of Human Rights and Economic Interests published by AAEI Despite international efforts to eradicate forced labor, it remains a pervasive issue. The International Labor Organization (ILO) estimates that on any given day, there are 28 million workers, including adults and children, subjected to forced labor globally (5). The…
How Tariffs Are Quietly Raising the Cost of Christmas
Tariffs on Chinese imports are pushing up the cost of artificial Christmas trees and holiday décor in the U.S., and many shoppers are noticing higher prices this season. Because the vast majority of artificial trees and decorations come from China, even relatively small tariff rates translate into noticeable price hikes at retail. Why Tariffs Hit…
Enforcement of the Uyghur Forced Labor Prevention Act
The Uyghur Forced Labor Prevention Act (UFLPA) went into effect on June 21, 2022. The UFLPA has three key provisions: It creates a rebuttable presumption that all items produced, in whole or in part, in the Xinjiang region of China are made with forced labor. It requires Customs and Border Protection to create an Entity…
Mexico becomes first country to pass USMCA
Mexico’s Senate on Wednesdaypassed the USMCA, making it the first country to ratify the new North American trade pact. “USMCA passes! Mexico goes first with clear signal that our economy is open,” Jesús Seade, Mexico’s undersecretary for foreign affairs, wrote on Twitter. “We’re confident that our partners will soon do the same,” Seade added. Passage in Mexico…
Dutch Lawmakers Question New U.S. Export Restrictions on ASML Chip Machines
Dutch lawmakers are raising concerns over the new U.S. export restrictions targeting ASML chip machines. These restrictions could have implications for the manufacturing of deep ultraviolet (DUV) lithography machines produced by ASML Holding and exported from the Netherlands to China. Let’s dive into the details. Understanding the New Rules The U.S. recently introduced new export…
Indian Pharma Giants Face Uncertainty as Trump Proposes 25% Import Tariffs
Indian pharmaceutical companies with significant exposure to the US market are bracing for potential disruption as former US President Donald Trump plans to impose a 25% or higher tariff on pharmaceutical imports. This move could have far-reaching implications for India’s thriving generic drug industry, which considers the US its largest export market. Key points: While…
